Priority Date: 06.12.11 (US 201161567384P)

PYRROLOPYRIMIDINES AS JANUS KINASE INHIBITORS

  • Application ID: EP12855868
  • Status: █ EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Merck & Co. Inc.
Technology Company

Attorneys

Missing person image small
David Robert Jaap
no operation time available
Merck & Co. Inc.
4 offices
Technology Company
Missing person image small
David Robert Jaap
no operation time available
Merck Sharp & Dohme Ltd.
7 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Merck & Co. Inc. and Merck Sharp & Dohme Ltd. are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 224 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 06.12.2011 - Priority Date (US 201161567384P)
  • 13.06.2013 - Publication A1 (WO2013085802)
  • 15.10.2014 - Publication A1 (EP2788000)

IPC Classification